Drug products patented sales in Canada by therapeutic class 2022

Published by
Matej Mikulic,
Mar 26, 2024
This statistic displays the sales of patented drug products in Canada in 2022, sorted by therapeutic class. Antineoplastics and immunomodulating agents generated around 8.1 billion Canadian dollars of revenue.

Patented drug products sales in Canada in 2022, by therapeutic class (in million Canadian dollars)

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2024

Region

Canada

Survey time period

2022

Supplementary notes

* These groups have been combined for reasons of confidentiality.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Top pharmaceutical drugs "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Top pharmaceutical drugs

Global overview

3

Top companies' top products

5

Best-selling drugs

7

U.S. overview

5

Outlook

5

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in CanadaGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPharmaceutical research and development (R&D)
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu